Zusammenfassung
Die Thematik „Zytokine und Akute-Phase-Proteine in der Differentialdiagnose von M. Crohn/Colitis ulcerosa versus intestinale Infektionen“ impliziert hohe Erwartungen. Zunächst soll dargestellt werden, welche Zytokine und ggf. Akute-Phase-Proteine bei den genannten Erkrankungen eine Rolle spielen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Braegger CP, Nicholls S, Murch SH (1992) Tumor necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 339: 89–91
Casini-Raggi V, Kam L, Chong YJT (1995) Mucosal imbalance of IL-1 and IL-1-receptor antagonist in inflammatory bowel disease. J Immunol 154:2434–2440
Dinarello CA (2000) Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 11:483–486
Duchmann R, Neurath M, Märker-Herrman E, Meyer zum Büschenfelde K-H (1997) Immune response towards intestinal bacteria - current concepts and future perspectives. Z Gastroenterol 35:337–346
Elewaut D, DiDonato JA, Kinn JM, Truong F, Eckmann L, Kagnoff MF (1999) NF-KB is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J Immunol 163: 1457–1466
Fleckenstein JM, Kopecko DJ (2001) Breaching the mucosal barrier by stealth: an emerging pathogenic mechanism for enteroadherent bacterial pathogens. J Clin Invest 107:27–30.
Hadziselimovic F, Emmons LR, Gallati H (1995) Soluble tumour necrosis factor receptors p55 and p75 in the urine monitor disease activity and the efficacy of treatment of inflammatory bowel disease. Gut 37:260–263
Hickey TE, Bagar S, Bourgeois L, Ewing CP, Guerry P (1999) Campylobacter jejuni- stimulated secretion of interleukin-8 by INT407 cells. Infect Immun 67:88–93
Higgins LM, Frankel G, Douce G, Dougan G, MacDonald TT (1999) Citrobacter rodentium infection in mice elicits a mucosal Thl cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect Immun 67:3031–3039
Hyams J, Treem W, Eddy E (1991) Tumor necrosis factor alpha is not elevated in chil- dren with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 12:233–236
Jensen LE, Whitehead AS (1998) Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J 334:489–503
Kampik D, Schulte R, Autenrieth IB (2000) Yersinia enterocolitica invasin protein triggers differential production of interleukin-1, interleukin-8, monocyte chemoattractant protein 1, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor alpha in epithelial cells: Implications for understanding the early cytokine network in yersinia infections. Infect Immun 68: 2484–2492
Keshhavarzian A, Fusunyan RD, Jacyno M (1999) Increased interleukin-8 in rectal dialysate from patients with ulcerative colitis. Evidence for a biologival role for IL-8 in inflammation of the colon. Am J Gastroenterol 94:704–712
Kusugami K, Fukatsu A, Tanimoto M (1995) Elevation of interleukin-6 in inflammatory bowel disease is macrophage-and epithelial cell dependent. Dig Dis Sci 40:949–959
MacDonald TT, Monteleone G, Pender SLF (2000) Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 51: 2–9
Maeda M, Watanabe N, Neda H (1992) Serum tumor necrosis factor activity in inflame-matory bowel disease. Immunopharmacol Immunotoxicol 14: 451–461
Mangiarotti P, Moulin F, Palmer P, Ravilly S, Raymond J, Gendrel D (1999) Interferon- alpha in viral and bacterial gastroenteritis: a comparison with C-reactive protein and interleukin-6. Acta Paediatr 88: 592–594
Mitsuyama K, Toyonaga A, Sasaki E (1995) Soluble interleukin-6 -receptors in inflame-matory bowel disease:Relation to circulating interleukin-6. Gut 36: 45–49
Moshage H (1997) Cytokines and the hepatic acute phase response. J Pathol 181: 257–266
Murch S, Lamkin V, Savage M (1991) Serum concentrations of tumour necrosis factoralpha in childhood chronic inflammatory bowel disease. Gut 32:913–917
Nicholls S, Stephens S, Braegger C (1993) Cytokines in stools of children with inflam-matory bowel disease or infective diarrhea. J Clin Pathol 46: 757–760
Nielsen OH, Brynskov J, Bendtzen K (1993) Circulating and mucosal concentrations of tumor necrosis factor and inhibitor(s) in inflammatory bowel disease. Dan Med Bull 40: 247–249
Nielsen OH, Brynskow J (1993) Soluble interleukin-2-receptors in ulcerative colitis. Mediat Inflamm 2:115–118
Nielsen OH, Ciardelli T, Wu Z (1995) Circulating soluble interleukin-2-receptor a-and b-chain in inflammatory bowel disease. Am J Gastroenterol 90:1301–1306
Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NHH (2000) Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 95: 359–367
Papadakis KA, Targan SR (2000) Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 51: 289–298
Parrello T, Monteleone G, Cuchiara S, Monteleone I, Sebkova L, Doldo P, Luzza F, Pal-lone F (2000) Up-regulation of the IL-12-receptor beta 2 chain in Crohn’s disease. J Immunol 165: 7234–7239
Raquib R, Lindberg AA, Wretlind B, Bardhan PK, Andersson U, Andersson J (1995) Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun 63: 289–296
Rubhana R, Lindberg AA, Björk L, Bardhan PK, Wretlind B, Andersson U, Andersson J (1995) Down-regulation of gamma-interferon, tumour necrosis factor type 1, interleukin-1 (IL-1) type I, IL-3, IL-4, and transforming growth factor b type I receptors at the local site during the acute phase of Shigella infection. Infect Immun 63: 3079–3087
Saiki T, Mitsuyama K, Toyonaga A (1998) Detection of pro-and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease. Scand J Gastroenterol 33:616–622
Sategna-Guidetti C, Pulitano R, Fenoglio L (1993) Tumour necrosis factor in Crohn’s disease. Relation of serum concentration to disease activity. Recenti Prog Med 84: 93–99
Schulte R, Grassi GA, Preger S, Fessele S, Jacobi CA, Schaller M, Nelson PJ, Autenrieth IB (2000) Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers. FASEB J 14:1471–1484
Stroinkhorst A, Jansen J, Tytgat G (1994) Soluble IL-2 and TNF-receptors p55 and p75 in Crohn’s disease. Gastroenterology 106: A779
Williams AJ, Symons JA, Watchet K (1992) Soluble interleukin-2-receptor and disease activity in Crohn’s disease. J Autoimmun 5:251–259
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Göke, M. (2001). Stellenwert von Akutphaseproteinen und Zytokinen. In: Stein, J., Dignass, A. (eds) Chronisch entzündliche Darmerkrankungen. Gastroenterologie Update, vol 2001. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59505-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-59505-9_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42509-0
Online ISBN: 978-3-642-59505-9
eBook Packages: Springer Book Archive